Novo Nordisk’s Wegovy and copyright, each powered by semaglutide, have revolutionized obesity remedy through unparalleled weight loss results. California biotech behemoth Amgen ditched designs for an experimental weight loss pill in Could but remains hoping for a slice of the marketplac